Skip to main content
. 2017 May 11;7:1728. doi: 10.1038/s41598-017-01572-z

Figure 5.

Figure 5

SC-43 treatment induces apoptosis of hepatic stellate cells. (a) Dose-escalation effects of SC-43 and sorafenib administered for 24 h on the cell viability of LX2 and HSC-T6 cells. (b) Dose-escalation and time-dependent effects of SC-43 administration for 24 h or 48 h on the cell viability of primary mouse HSCs. (c) Dose-escalation effects of SC-43 and sorafenib administration for 24 h on the apoptosis of LX2 and HSC-T6 cells. (d) SC-43 induced LX2 and HSC-T6 apoptosis by increasing the cleaved PARP fragments. (e) The SC-43-induced downregulation of the TGF-β pathway in LX2 cells. (f) The SC-43-induced downregulation of p-PDGFR and p-Akt in the PDGF pathway in LX2 and HSC-T6 cells. Columns: mean and bars: standard error (n = 3–4). *P < 0.05, **P < 0.01, and ***P < 0.001.